ADG153, an Anti-CD47 Monoclonal Antibody Prodrug, Has Strong In Vivo Anti-Tumor Activity, Minimal RBC-Related and Antigen Sink Liabilities, and Extended Half Life in Comparison with Benchmark Clinical Antibodies of the Same IgG SubclassBin Cai, Jiangchun Xu, Aaron Nguyen et al.|Blood|2021Cited by 4
Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: a meta-analysisGuizhong Liu, Chunxiao Xue, Yingjie Wang et al.|Tumor Biology|2013Cited by 2